Atazanavir’s Effects on CV Risks in HIV Infected Veterans

by U.S. Medicine

December 15, 2017

SALT LAKE CITY—Patients with HIV infection have an increased risk of cardiovascular disease compared with uninfected individuals. Oftentimes, they receive antiretroviral therapy with atazanavir (ATV), which delays progression of atherosclerosis markers.

Whether the treatment also reduces cardiovascular disease event risk compared with other antiretroviral regimens is unknown, however, according to a study in the journal AIDS.1

Researchers from the Salt Lake City VAMC and other institutions conducted a population-based, noninterventional, historical cohort study conducted from July 1, 2003, through Dec. 31, 2015, to better understand the effects. The focus was on 9,500 treatment-naïve HIV-infected patients at VHA hospitals and clinics through the United States. Participants were initiating antiretroviral regimens containing ATV, other protease inhibitors, nonnucleoside reverse transcriptase inhibitors (NNRTIs) or integrase strand transfer inhibitors (INSTIs).

The study team analyzed incidence rates of myocardial infarction (MI), stroke and all-cause mortality within each regimen: ATV vs. other protease inhibitor, NNRTI, or INSTI.

Results indicated that incidence rates for MI, stroke and all-cause mortality with ATV-containing regimens (5.2, 10.4, and 16.0 per 1,000 patient-years, respectively) were lower than with regimens containing other protease inhibitors (10.2, 21.9, and 23.3 per 1,000 patient-years), NNRTIs (7.5, 15.9, and 17.5 per 1,000 patient-years) or INSTIs (13.0, 33.1, and 21.5 per 1,000 patient-years). 

After inverse probability of treatment-weighting, adjusted hazard ratios for MI, stroke and all-cause mortality with ATV-containing regimens vs. all non-ATV-containing regimens were 0.59 (0.41-0.84), 0.64 (0.50-0.81), and 0.90 (0.73-1.11), respectively.

“Among treatment-naive HIV-infected patients in the Veterans Health Administration initiating ATV-containing regimens, risk of both MI and stroke were significantly lower than in those initiating regimens containing other protease inhibitors, NNRTIs or INSTIs,” researchers concluded.

  1. LaFleur J, Bress AP, Rosenblatt L, Crook J, Sax PE, Myers J, Ritchings C. Cardiovascular outcomes among HIV-infected veterans receiving atazanavir. AIDS. 2017 Sep 24;31(15):2095-2106. doi: 10.1097/QAD.0000000000001594. PubMed PMID: 28692532; PubMed Central PMCID: PMC5603981.

Comments are closed here.


Related Articles

Low to No Alcohol Use Optimizes Health Outcomes in HIV Patients

SEATTLE—For years, physicians have encouraged patients diagnosed with human immunodeficiency virus to minimize or avoid drinking alcohol. But how much does it really matter? “Controlled alcohol use over time, especially nonuse or very low-level use,... View Article

Army Researchers Identify a CV Bonus from Early ART Initiation in HIV

SAN ANTONIO, TX—ART has never looked better, at least if you’re an individual recently diagnosed with human immunodeficiency virus.  Researchers at the Brooke Army Medical Center in San Antonio recently determined that antiretroviral therapy reverses... View Article


U.S. Medicine Recommends


More From hiv

HIV

Low to No Alcohol Use Optimizes Health Outcomes in HIV Patients

SEATTLE—For years, physicians have encouraged patients diagnosed with human immunodeficiency virus to minimize or avoid drinking alcohol. But how much does it really matter? “Controlled alcohol use over time, especially nonuse or very low-level use,... View Article

HIV

Army Researchers Identify a CV Bonus from Early ART Initiation in HIV

SAN ANTONIO, TX—ART has never looked better, at least if you’re an individual recently diagnosed with human immunodeficiency virus.  Researchers at the Brooke Army Medical Center in San Antonio recently determined that antiretroviral therapy reverses... View Article

HIV

HIV Patients Had Lower PC Incidence in VA Study

NEW YORK—Non-AIDS defining cancers are increasingly important contributors to health outcomes for aging persons with HIV (PWH), according to a recent conference presentation. The presentation also pointed out that, although prostate cancer is prevalent in... View Article

HIV

HIV Infection Linked to 40% Increase in Veterans’ Risk of Developing Heart Failure

Antiretroviral therapy has extended the lives of veterans with human immunodeficiency virus (HIV) by decades, but a new threat could cut back their longevity.

HIV

Infectious Disease Specialist Uses Telehealth for Rural Veterans With HIV

Veterans living in rural areas face a lot of challenges, the most common of which is having to travel long distances to access VA medical care.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up